Enhancing the QUAlity and Transparency Of health Research
Search for reporting guidelines
Use your browser's Back button to return to your search results
Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective
| Reporting guideline provided for? (i.e. exactly what the authors state in the paper) |
Reporting clinically relevant and more informative adverse event information in clinical trial publications. |
| Full bibliographic reference | Lineberry N, Berlin JA, Mansi B, Glasser S, Berkwits M, Klem C, Bhattacharya A, Citrome L, Enck R, Fletcher J, Haller D, Chen TT, Laine C. Recommendations to improve adverse event reporting in clinical trial publications: a joint pharmaceutical industry/journal editor perspective. BMJ. 2016;355:i5078. |
| Language | English |
| PubMed ID | 27697753 |
| Study design | Clinical trials, Experimental studies |
| Applies to the whole report or to individual sections of the report? | Harms/adverse effects/safety data |
| Record last updated on | October 11, 2016 |